The closing price of Lyell Immunopharma Inc (NASDAQ: LYEL) was $2.16 for the day, down -2.26% from the previous closing price of $2.21. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 1538248 shares were traded. LYEL stock price reached its highest trading level at $2.3200 during the session, while it also had its lowest trading level at $2.1400.
Ratios:
Our analysis of LYEL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.07 and its Current Ratio is at 16.07. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on August 28, 2023, Downgraded its rating to Neutral and sets its target price to $5 from $15 previously.
On November 14, 2022, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $15 to $7.
Goldman Downgraded its Buy to Neutral on November 11, 2022, whereas the target price for the stock was revised from $13 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’23 when Klausner Richard sold 58,020 shares for $2.28 per share. The transaction valued at 132,286 led to the insider holds 930,880 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYEL now has a Market Capitalization of 548.85M and an Enterprise Value of 65.79M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4221.97 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 506.09 whereas that against EBITDA is -0.29.
Stock Price History:
Over the past 52 weeks, LYEL has reached a high of $3.97, while it has fallen to a 52-week low of $1.32. The 50-Day Moving Average of the stock is 2.1657, while the 200-Day Moving Average is calculated to be 2.2337.
Shares Statistics:
LYEL traded an average of 1.17M shares per day over the past three months and 864k shares per day over the past ten days. A total of 253.96M shares are outstanding, with a floating share count of 116.53M. Insiders hold about 54.14% of the company’s shares, while institutions hold 27.92% stake in the company. Shares short for LYEL as of Feb 29, 2024 were 10.95M with a Short Ratio of 9.33, compared to 10.84M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.31% and a Short% of Float of 6.14%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.24, while EPS last year was -$0.27. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.18 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.74 and -$0.97 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$0.89, with 3 analysts recommending between -$0.81 and -$1.02.
